BOSTON, April 23, 2025 /PRNewswire/ -- Whistleblower Law Collaborative LLC is pleased to announce that the United States has settled a False Claims Act case alleging genetic testing fraud brought by two of its clients against Genexe, LLC d/b/a Genexe Health, Immerge, Inc., the parent company of Genexe, and two individual owners, Jason Green and Jason Gross.
Under the terms of the government settlement announced today, these defendants collectively will pay $6 million to resolve allegations of genetic testing fraud brought in multiple FCA qui tam cases filed by several whistleblowers, including clients of WLC. The whistleblowers collectively will receive an award of $1.3 million from the settlement.
Government's Allegations of Genetic Testing Fraud
Genetic tests are medical laboratory tests designed to identify specific inherited mutations in a patient's genes. Genetic mutations or variations may affect a patient's risk of developing certain diseases or the patient's response to medications. Medicare does not cover clinical laboratory tests that are not medically necessary or that are tainted by kickbacks.
After investigating the claims raised in the relators' FCA qui tam complaints, the United States alleged that during 2018 and 2019, Genexe, Immerge, Green, and Gross assisted with and caused to be submitted false claims to Medicare for CGx and PGx tests that were not medically necessary and that were procured through kickbacks offered and paid to a network of independent...
With a growing share of insurance executives viewing generative artificial intelligence as a tool for streamlining and improving functions like fraud detection, Deloitte predicts that AI technolog...